AU2015238195C1 - Mitochondrial markers of neurodegenerative diseases - Google Patents
Mitochondrial markers of neurodegenerative diseases Download PDFInfo
- Publication number
- AU2015238195C1 AU2015238195C1 AU2015238195A AU2015238195A AU2015238195C1 AU 2015238195 C1 AU2015238195 C1 AU 2015238195C1 AU 2015238195 A AU2015238195 A AU 2015238195A AU 2015238195 A AU2015238195 A AU 2015238195A AU 2015238195 C1 AU2015238195 C1 AU 2015238195C1
- Authority
- AU
- Australia
- Prior art keywords
- sites
- loop region
- disease
- chg
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201430444A ES2546743B1 (es) | 2014-03-28 | 2014-03-28 | Marcadores mitocondriales de enfermedades neurodegenerativas |
| ESP201430444 | 2014-03-28 | ||
| PCT/ES2015/070230 WO2015144964A2 (es) | 2014-03-28 | 2015-03-27 | Marcadores mitocondriales de enfermedades neurodegenerativas |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| AU2015238195A1 AU2015238195A1 (en) | 2016-10-27 |
| AU2015238195B2 AU2015238195B2 (en) | 2019-07-18 |
| AU2015238195C1 true AU2015238195C1 (en) | 2022-03-10 |
Family
ID=54150970
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2015238195A Active AU2015238195C1 (en) | 2014-03-28 | 2015-03-27 | Mitochondrial markers of neurodegenerative diseases |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11053549B2 (enExample) |
| EP (1) | EP3124621B9 (enExample) |
| JP (1) | JP6687532B2 (enExample) |
| AU (1) | AU2015238195C1 (enExample) |
| BR (1) | BR112016022582B1 (enExample) |
| CA (1) | CA2944281C (enExample) |
| DK (1) | DK3124621T3 (enExample) |
| ES (2) | ES2546743B1 (enExample) |
| PT (1) | PT3124621T (enExample) |
| WO (1) | WO2015144964A2 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107904667A (zh) * | 2018-01-02 | 2018-04-13 | 上海美吉生物医药科技有限公司 | 一种新型甲基化建库试剂盒及其应用 |
| CN108841928B (zh) * | 2018-06-11 | 2021-11-23 | 河北医科大学 | 一种人类线粒体基因组甲基化检测试剂盒及其应用 |
| CN109358194A (zh) * | 2018-09-29 | 2019-02-19 | 中国海洋大学 | 凡纳滨对虾高血糖激素间接竞争酶联免疫检测方法 |
| CN112813159B (zh) * | 2021-03-23 | 2023-05-30 | 广州金域医学检验中心有限公司 | 帕金森病的生物标志物及其应用 |
| EP4490322A1 (en) * | 2022-03-11 | 2025-01-15 | Admit Therapeutics SL | Methods of determining the risk of developing alzheimer's disease dementia |
| WO2024008759A1 (en) | 2022-07-04 | 2024-01-11 | Admit Therapeutics Sl | Method for identifying dementia with lewy bodies in a subject |
| CN119144600B (zh) * | 2024-11-20 | 2025-04-01 | 天津赛萌生物技术有限公司 | 一种含鲑鱼线粒体基因克隆载体的构建及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT975800E (pt) | 1997-02-27 | 2003-10-31 | Ingeneus Corp | Doseamento de nucleotidos em solucao usando sondas anp |
| WO2000063441A2 (en) * | 1999-04-20 | 2000-10-26 | Mitokor | Single nucleotide polymorphisms in mitochondrial genes that segregate with alzheimer's disease |
| WO2003046225A1 (en) | 2001-11-26 | 2003-06-05 | Mitokor | Mitochondrial dna polymorphisms |
| JP2005000044A (ja) | 2003-06-10 | 2005-01-06 | Masatsugu Tanaka | ヒトミトコンドリア遺伝子変異に基づく遺伝子検出法 |
| US20120232016A1 (en) | 2011-03-08 | 2012-09-13 | Coleman Paul D | Method and system to detect and diagnose alzheimer's disease |
-
2014
- 2014-03-28 ES ES201430444A patent/ES2546743B1/es not_active Expired - Fee Related
-
2015
- 2015-03-27 US US15/300,248 patent/US11053549B2/en active Active
- 2015-03-27 JP JP2016560431A patent/JP6687532B2/ja active Active
- 2015-03-27 EP EP15770042.8A patent/EP3124621B9/en active Active
- 2015-03-27 AU AU2015238195A patent/AU2015238195C1/en active Active
- 2015-03-27 BR BR112016022582-1A patent/BR112016022582B1/pt active IP Right Grant
- 2015-03-27 WO PCT/ES2015/070230 patent/WO2015144964A2/es not_active Ceased
- 2015-03-27 PT PT15770042T patent/PT3124621T/pt unknown
- 2015-03-27 DK DK15770042.8T patent/DK3124621T3/da active
- 2015-03-27 CA CA2944281A patent/CA2944281C/en active Active
- 2015-03-27 ES ES15770042T patent/ES2744592T3/es active Active
-
2021
- 2021-06-02 US US17/337,355 patent/US12065702B2/en active Active
Non-Patent Citations (2)
| Title |
|---|
| TAKASAKI, S., "Japanese Alzheimer's disease and other complex disorders diagnosis based on mitochondrial SNP haplogroups", INTERNATIONAL JOURNAL OF A LZHEIMER'S DISEASE, (2012), vol. 2012, ISSN 2090-0252, page 245038 * |
| TAKASAKI, S., "Mitochondrial SNPs associated with Japanese centenarians, Alzheimer's patients, and Parkinson's patients", COMPUTATIONAL BIOLOGY AND CHEMISTRY, (2008), vol. 32, no. 5, ISSN 1476-9271, pages 332 - 337 * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2015238195B2 (en) | 2019-07-18 |
| JP2017511138A (ja) | 2017-04-20 |
| EP3124621B9 (en) | 2020-10-21 |
| BR112016022582B1 (pt) | 2024-03-12 |
| CA2944281C (en) | 2021-05-18 |
| CA2944281A1 (en) | 2015-10-01 |
| AU2015238195A1 (en) | 2016-10-27 |
| EP3124621B1 (en) | 2019-06-05 |
| US20170137881A1 (en) | 2017-05-18 |
| BR112016022582A2 (pt) | 2017-10-10 |
| ES2546743B1 (es) | 2016-07-07 |
| US20220049307A1 (en) | 2022-02-17 |
| WO2015144964A3 (es) | 2015-12-17 |
| ES2546743A1 (es) | 2015-09-28 |
| EP3124621A2 (en) | 2017-02-01 |
| PT3124621T (pt) | 2019-09-23 |
| DK3124621T3 (da) | 2019-09-09 |
| US12065702B2 (en) | 2024-08-20 |
| EP3124621A4 (en) | 2018-02-14 |
| US11053549B2 (en) | 2021-07-06 |
| JP6687532B2 (ja) | 2020-04-28 |
| WO2015144964A2 (es) | 2015-10-01 |
| ES2744592T3 (es) | 2020-02-25 |
| ES2744592T9 (es) | 2020-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12065702B2 (en) | Mitochondrial markers of neurodegenerative diseases | |
| US6475736B1 (en) | Methods for genetic analysis of DNA using biased amplification of polymorphic sites | |
| WO2001090419A9 (en) | Methods for genetic analysis of dna to detect sequence variances | |
| CA2782207A1 (en) | Polymorphisms associated with parkinson's disease | |
| US7435541B2 (en) | Restriction enzyme genotyping | |
| US20140193809A1 (en) | Methods for genetic analysis of dna to detect sequence variances | |
| US10954563B2 (en) | Method for predicting the onset of extrapyramidal symptoms (EPS) induced by an antipsychotic-based treatment | |
| AU2006301578B9 (en) | Method for diagnosing thromboembolic disorders and coronary heart diseases | |
| JP4675330B2 (ja) | シャルコー・マリー・ツース病２ａ型の検出方法 | |
| KR101249635B1 (ko) | 양극성 장애 진단용 ｅｇｒ2 유전자 ｓｎｐ, 그를 포함하는 마이크로어레이 및 키트 | |
| US20030082537A1 (en) | Methods for genetic analysis of DNA to detect sequence variances | |
| US20060166219A1 (en) | NTRK1 genetic markers associated with progression of Alzheimer's disease | |
| US20050250122A1 (en) | APOA4 genetic markers associated with progression of Alzheimer's disease | |
| US20050250121A1 (en) | NTRK2 genetic markers associated with progression of Alzheimer's disease | |
| US20050255492A1 (en) | CHRNA9 genetic markers associated with progression of Alzheimer's disease | |
| JP4220906B2 (ja) | 統合失調症をスクリーニングするためのプライマーおよびその方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| DA2 | Applications for amendment section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 10 NOV 2021 |
|
| DA3 | Amendments made section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 10 NOV 2021 |